Insight Molecular Diagnostics Stock Price, News & Analysis
IMDX
NASDAQ
Company Description
Welcome to the overview page for Insight Molecular Diagnostics (IMDX), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$7.43
+0.47%
+0.03
Last updated: November 16, 2025 at 15:59
134.18 %
Performance 1 year
$225.0M
28.7M
Latest News
SEC Filings
Financial Highlights
$518,000
Revenue (TTM)
-$9,742,000
Net Income (TTM)
-$0.30
-$6,279,000
Operating Cash Flow
-1,880.70%
-1,900.00%
Upcoming Events
NOV
19
November 19, 2025
Marketing
CEO at NASH25 conference
Josh Riggs attends Stephens NASH25 in Nashville; investors can request one-on-one meetings
DEC
31
December 31, 2025
Regulatory
GraftAssureDx FDA submission
Submission of GraftAssureDx transplant monitoring assay to FDA
DEC
31
December 31, 2025
Clinical
Clinical trial completion
Observational study completion for GraftAssureDx trial (up to 125 patients)
DEC
31
DEC
31
JAN
01
January 1, 2026 - December 31, 2026
Product
GraftAssure kit launch
Kitted clinical launch of GraftAssure family planned in 2026
MAY
01
May 1, 2026 - August 31, 2026
Product
Product launch
Anticipated launch of GraftAssureDx in mid-2026
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Insight Molecular Diagnostics (IMDX)?
The current stock price of Insight Molecular Diagnostics (IMDX) is $7.4 as of November 14, 2025.
What is the market cap of Insight Molecular Diagnostics (IMDX)?
The market cap of Insight Molecular Diagnostics (IMDX) is approximately 225.0M. Learn more about what market capitalization means .
What is the revenue (TTM) of Insight Molecular Diagnostics (IMDX) stock?
The trailing twelve months (TTM) revenue of Insight Molecular Diagnostics (IMDX) is $518,000.
What is the net income of Insight Molecular Diagnostics (IMDX)?
The trailing twelve months (TTM) net income of Insight Molecular Diagnostics (IMDX) is -$9,742,000.
What is the earnings per share (EPS) of Insight Molecular Diagnostics (IMDX)?
The diluted earnings per share (EPS) of Insight Molecular Diagnostics (IMDX) is -$0.30 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Insight Molecular Diagnostics (IMDX)?
The operating cash flow of Insight Molecular Diagnostics (IMDX) is -$6,279,000. Learn about cash flow.
What is the profit margin of Insight Molecular Diagnostics (IMDX)?
The net profit margin of Insight Molecular Diagnostics (IMDX) is -1,880.70%. Learn about profit margins.
What is the operating margin of Insight Molecular Diagnostics (IMDX)?
The operating profit margin of Insight Molecular Diagnostics (IMDX) is -1,900.00%. Learn about operating margins.
What is the gross margin of Insight Molecular Diagnostics (IMDX)?
The gross profit margin of Insight Molecular Diagnostics (IMDX) is 67.57%. Learn about gross margins.
What is the current ratio of Insight Molecular Diagnostics (IMDX)?
The current ratio of Insight Molecular Diagnostics (IMDX) is 4.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the gross profit of Insight Molecular Diagnostics (IMDX)?
The gross profit of Insight Molecular Diagnostics (IMDX) is $350,000 on a trailing twelve months (TTM) basis.
What is the operating income of Insight Molecular Diagnostics (IMDX)?
The operating income of Insight Molecular Diagnostics (IMDX) is -$9,842,000. Learn about operating income.